Back to Top
Go Back
Journal Photo for The Lancet
Peer reviewed only Open Access

The Lancet (The Lancet)

Publisher : ELSEVIER SCIENCE INC
Medicine Dentistry
Claim Your Journal Get PRC Visit Website
e-ISSN 1474-547X
p-ISSN 0140-6736
Issue Frequency weekly
Est. Year 1924
Mobile 01425462736
Language English
APC YES
Impact Factor Assignee Google Scholar
Email pressoffice@lancet.com

Journal Descriptions

Since Thomas Wakley founded The Lancet in 1823, we have strived to make science widely available so that medicine can serve and transform society, and positively impact the lives of people. We are proud to have published papers that have made a crucial contribution to science and human health. You can view a selection of our research landmarks from more than 10 000 published issues. In 2023, The Lancet celebrated its 200th anniversary. Explore how we marked our bicentennial year across The Lancet Group. The Lancet invites submissions of any original contribution that advances or illuminates medical science or practice. We publish Articles (including randomised controlled trials and meta-analyses), Review, Seminar, Health Policy, Therapeutics, Comment, Clinical Picture, Correspondence, and World Report. We also publish Series and Commissions that aim to shape and drive positive change in clinical practice, and public and global health policy. Learn more about the types of papers we publish.

The Lancet (The Lancet) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Medicine, Dentistry , Online or Print , weekly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0140-6736, E-ISSN: 1474-547X, Established: 1924,
  • Does Not Provide Crossref DOI

  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing

Role In Research Journal

C. Noel Bairey Merz Profile Photo
C. Noel Bairey Merz
Editor

Publications of The Lancet

Men who have sex with men: stigma and discrimination
Travis S. K. Kong July, 2012
The first cases of AIDS were identified in gay men in the USA, and the disease was originally termed gay-related immune deficiency (GRID). Mobilisation of attention and resources was slow, p...
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consort...
Emelia J. Benjamin December, 2019
Background The relevance of blood lipid concentrations to long-term incidence of cardiovascular disease and the relevance of lipid-lowering therapy for cardiovascular disease outcomes is un...
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
Emelia J. Benjamin May, 2010
Background Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)), an inflammatory enzyme expressed in atherosclerotic plaques, is a therapeutic target being assessed in trials of vascular d...
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study
Emelia J. Benjamin December, 2008
Background Hyperuricaemia, a highly heritable trait, is a key risk factor for gout. We aimed to identify novel genes associated with serum uric acid concentration and gout. Methods Genome...
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
Emelia J. Benjamin March, 2012
Background Persistent inflammation has been proposed to contribute to various stages in the pathogenesis of cardiovascular disease. Interleukin-6 receptor (IL6R) signalling propagates downs...
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
Emelia J. Benjamin April, 2012
Background A high circulating concentration of interleukin 6 is associated with increased risk of coronary heart disease. Blockade of the interleukin-6 receptor (IL6R) with a monoclonal ant...
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study
Emelia J. Benjamin February, 2009
Background Atrial fibrillation contributes to substantial increases in morbidity and mortality. We aimed to develop a risk score to predict individuals' absolute risk of developing the cond...
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
Emelia J. Benjamin July, 2015
Background Comprehensive long-term data on atrial fibrillation trends in men and women are scant. We aimed to provide such data through analysis of the Framingham cohort over 50 years. Met...
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Emelia J. Benjamin January, 2010
Background Associations of C-reactive protein (CRP) concentration with risk of major diseases can best be assessed by long-term prospective follow-up of large numbers of people. We assessed...
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease ...
Mohsen Naghavi December, 2012
Background Non-fatal health outcomes from diseases and injuries are a crucial consideration in the promotion and monitoring of individual and population health. The Global Burden of Disease...